Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Meir Kestenbaum"'
Autor:
Ofir Sade, Daphna Fischel, Noa Barak-Broner, Shir Halevi, Irit Gottfried, Dana Bar-On, Stefan Sachs, Anat Mirelman, Avner Thaler, Aviv Gour, Meir Kestenbaum, Mali Gana Weisz, Saar Anis, Claudio Soto, Melanie Shanie Roitman, Shimon Shahar, Kathrin Doppler, Markus Sauer, Nir Giladi, Nirit Lev, Roy N. Alcalay, Sharon Hassin-Baer, Uri Ashery
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 17 (2024)
Alpha-synuclein (aSyn) aggregates in the central nervous system are the main pathological hallmark of Parkinson’s disease (PD). ASyn aggregates have also been detected in many peripheral tissues, including the skin, thus providing a novel and acces
Externí odkaz:
https://doaj.org/article/fb9c6cb2b32745928068125ebd86b591
Autor:
Tanya Gurevich, David Arkadir, Samih Badarny, Sandra Benizri, Oren Cohen, Ruth Djaldetti, Sharon Hassin-Baer, Meir Kestenbaum, Zeev Nitsan, Yair Zlotnik, Gilad Yahalom
Publikováno v:
Frontiers in Aging Neuroscience, Vol 14 (2022)
Parkinson’s disease (PD) is taking a staggering toll on healthcare systems worldwide, with the bulk of the expenditures invested in the late stages of the disease. Considering the rising life expectancy and the increasing prevalence of PD across th
Externí odkaz:
https://doaj.org/article/5199e226d450424ca0469361e6d381a7
Autor:
Jake DeBroff, Nurit Omer, Batsheva Cohen, Nir Giladi, Meir Kestenbaum, Julia C. Shirvan, Jesse M. Cedarbaum, Mali Gana‐Weisz, Orly Goldstein, Avi Orr‐Urtreger, Anat Mirelman, Avner Thaler
Publikováno v:
Movement Disorders Clinical Practice. 10:606-616
Autor:
Mali Gana-Weisz, Meir Kestenbaum, Julia C Shirvan, Shani Shenhar-Tsarfaty, Tanya Gurevich, Avi Orr-Urtreger, Anat Bar-Shira, Avner Thaler, Nurit Omer, Orly Goldstein, Keren Regev, Jesse M. Cedarbaum, Nir Giladi, Anat Mirelman
Publikováno v:
Journal of Parkinson's Disease
Background: Inflammation is an integral part of neurodegeneration including in Parkinson’s disease (PD). Ashkenazi Jews have high rates of genetic PD with divergent phenotypes among GBA-PD and LRRK2-PD. The role of inflammation in the prodromal pha
Publikováno v:
The Israel Medical Association journal : IMAJ. 24(8)
Autor:
Avi Orr-Urtreger, Anat Bar-Shira, Meir Kestenbaum, Nir Giladi, Jesse M. Cedarbaum, Shani Shenhar-Tsarfaty, Tanya Gurevich, Anat Mirelman, Mali Gana-Weisz, Orly Goldstein, Nurit Omer, Avner Thaler
Publikováno v:
Journal of Neurology. 268:1517-1525
The phenotype of Parkinson’s disease (PD) is variable with mutations in genes such as LRRK2 and GBA explaining part of this heterogeneity. Additional genetic and environmental factors contribute to disease variability. To assess the association bet
Autor:
Nir Giladi, Hedva Lerman, Meir Kestenbaum, Nanette Freedman, Tamara Shiner, Jonathan Kuten, Adi Linevitz, Einat Even-Sapir
Publikováno v:
Journal of Integrative Neuroscience, Vol 19, Iss 3, Pp 489-494 (2020)
Autonomic involvement, including cardiac denervation, may precede the motor symptoms of Parkinson’s disease by several years. L-3,4-dihydroxy-6-[18F] fluoro-phenylalanine is a positron emitter and a true analog of L-dopa, used in clinical practice
Autor:
Nir Giladi, Jesse M. Cedarbaum, Anat Bar-Shira, Avi Orr-Urtreger, Tanya Gurevich, Meir Kestenbaum, Orly Goldstein, Mali Gana-Weisz, Anat Mirelman, Nurit Omer, Avner Thaler
Publikováno v:
Movement Disorders. 35:1249-1253
BACKGROUND The phenotype of Parkinson's disease (PD) is milder among patients with LRRK2-PD and more severe among patients with GBA-PD; however, whether an additive phenotypical effect occurs among dual-mutation carriers requires validation. OBJECTIV
Autor:
Tanya Gurevich, Glenn T. Stebbins, Xuehan Ren, Meir Kestenbaum, Nir Giladi, Tali Taichman, Aya Bar David, Talia Herman, Alina Rosenberg, Achinoam Faust-Socher, H. Shabtai, Christopher G. Goetz, Sheng Luo, Chava Peretz, Marina Brozgol, Pablo Martinez-Martin, Saar Anis, Adi Ezra
Publikováno v:
Neuroepidemiology. 54:356-362
Background: The Unified Dyskinesia Rating Scale (UDysRS) is a well-established tool for producing comprehensive assessments of severity and disability associated with dyskinesia in patients with Parkinson’s disease (PD). The scale was originally de
Autor:
Hadeel Kinani, Belle Brahms-Tamir, Meir Kestenbaum, Ahmad Atamna, Ella Gordon, Gal Sahaf Levin, Emily Elefant, Feda Fanadka, Nirit Lev, Aviv Gour, Nofar Frenkel-Manzur, Roy Zaltzman
Publikováno v:
International Journal of Medical Science and Clinical Invention. 8:5299-5301
Background: Charcot-Marie-Tooth disease (CMT) is a heterogeneous group of disorders best known for causing inherited forms of peripheral neuropathy. History of CMT disease is not considered relevant in patients presenting with acute central neurologi